speb/financial-data huggingface dataset:
MRTN balance_sheet (annual, 2023-12-31) — Share Issued: 81312168.00
MRTN income_statement (annual, 2023-12-31) — Special Income Charges: 13612000.00
MRTN cash_flow (annual, 2023-12-31) — Stock Based Compensation: 2319000.00
MRTN balance_sheet (annual, 2023-12-31) — Stockholders Equity: 757386000.00
MRTN balance_sheet (annual, 2023-12-31) — Tangible Book Value: 757386000.00
MRTN income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 3412276.03
MRTN income_statement (annual, 2023-12-31) — Tax Provision: 23543000.00
MRTN income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.25
MRTN balance_sheet (annual, 2023-12-31) — Total Assets: 990339000.00
MRTN balance_sheet (annual, 2023-12-31) — Total Capitalization: 757386000.00
MRTN balance_sheet (annual, 2023-12-31) — Total Debt: 249000.00
MRTN balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 757386000.00
MRTN income_statement (annual, 2023-12-31) — Total Expenses: 1054957000.00
MRTN balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 232953000.00
MRTN balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 793757000.00
MRTN balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 122711000.00
MRTN income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 90110000.00
MRTN balance_sheet (annual, 2023-12-31) — Total Tax Payable: 0.00
MRTN income_statement (annual, 2023-12-31) — Total Unusual Items: 13612000.00
MRTN income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 13612000.00
MRTN balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
MRTN balance_sheet (annual, 2023-12-31) — Working Capital: 86340000.00
MRTN cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 6311000.00
MRTN income_statement (annual, 2024-12-31) — +Operating Expense: 102452000.00
MRTN income_statement (annual, 2024-12-31) — +Total Revenue: 963708000.00
MRTN balance_sheet (annual, 2024-12-31) — Accounts Payable: 25781000.00
MRTN balance_sheet (annual, 2024-12-31) — Accounts Receivable: 89992000.00
MRTN balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -370124000.00
MRTN balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 52941000.00
MRTN balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -496000.00
MRTN balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -496000.00
MRTN income_statement (annual, 2024-12-31) — Basic Average Shares: 81406000.00
MRTN income_statement (annual, 2024-12-31) — Basic EPS: 0.33
MRTN cash_flow (annual, 2024-12-31) — Beginning Cash Position: 53213000.00
MRTN cash_flow (annual, 2024-12-31) — Capital Expenditure: -233230000.00
MRTN balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 282000.00
MRTN balance_sheet (annual, 2024-12-31) — Capital Stock: 815000.00
MRTN balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 17267000.00
MRTN balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 17267000.00
MRTN cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -19540000.00
MRTN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -18622000.00
MRTN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -152138000.00
MRTN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 134814000.00
MRTN cash_flow (annual, 2024-12-31) — Change In Account Payable: -2439000.00
MRTN cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -5823000.00
MRTN cash_flow (annual, 2024-12-31) — Change In Payable: -2439000.00
MRTN cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -8262000.00
MRTN cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -4055000.00
MRTN cash_flow (annual, 2024-12-31) — Change In Receivables: 19831000.00
MRTN cash_flow (annual, 2024-12-31) — Change In Working Capital: 7514000.00
MRTN cash_flow (annual, 2024-12-31) — Changes In Cash: -35946000.00
MRTN balance_sheet (annual, 2024-12-31) — Common Stock: 815000.00
MRTN cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -19540000.00
MRTN balance_sheet (annual, 2024-12-31) — Common Stock Equity: 767922000.00
MRTN cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
MRTN income_statement (annual, 2024-12-31) — Cost Of Revenue: 833007000.00
MRTN balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 66673000.00
MRTN balance_sheet (annual, 2024-12-31) — Current Assets: 138511000.00
MRTN balance_sheet (annual, 2024-12-31) — Current Liabilities: 93519000.00
MRTN cash_flow (annual, 2024-12-31) — Deferred Income Tax: -15428000.00
MRTN cash_flow (annual, 2024-12-31) — Deferred Tax: -15428000.00
MRTN cash_flow (annual, 2024-12-31) — Depreciation: 111653000.00
MRTN cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 111653000.00
MRTN cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 111653000.00
MRTN income_statement (annual, 2024-12-31) — Diluted Average Shares: 81472000.00
MRTN income_statement (annual, 2024-12-31) — Diluted EPS: 0.33
MRTN income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 26922000.00
MRTN income_statement (annual, 2024-12-31) — EBIT: 28249000.00
MRTN income_statement (annual, 2024-12-31) — EBITDA: 139902000.00
MRTN cash_flow (annual, 2024-12-31) — End Cash Position: 17267000.00
MRTN cash_flow (annual, 2024-12-31) — Financing Cash Flow: -18622000.00
MRTN cash_flow (annual, 2024-12-31) — Free Cash Flow: -98416000.00
MRTN cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -4971000.00
MRTN income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 4971000.00
MRTN income_statement (annual, 2024-12-31) — General And Administrative Expense: 62138000.00
MRTN balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 90488000.00
MRTN balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 90488000.00
MRTN balance_sheet (annual, 2024-12-31) — Gross PPE: 1199315000.00
MRTN income_statement (annual, 2024-12-31) — Gross Profit: 130701000.00
MRTN cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 19170000.00
MRTN cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 10497000.00
MRTN balance_sheet (annual, 2024-12-31) — Income Tax Payable: 1065000.00
MRTN balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 1065000.00
MRTN income_statement (annual, 2024-12-31) — Insurance And Claims: 53109000.00
MRTN cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 0.00
MRTN cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 0.00
MRTN balance_sheet (annual, 2024-12-31) — Invested Capital: 767922000.00
MRTN cash_flow (annual, 2024-12-31) — Investing Cash Flow: -152138000.00
MRTN balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 282000.00
MRTN balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 282000.00
MRTN balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 60884000.00
MRTN balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 60884000.00
MRTN cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
MRTN income_statement (annual, 2024-12-31) — Net Income: 26922000.00
MRTN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 26922000.00
MRTN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 26922000.00
MRTN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 26922000.00
MRTN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 26922000.00
MRTN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 26922000.00
MRTN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 26922000.00
MRTN cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -382000.00
MRTN cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -49000.00
MRTN balance_sheet (annual, 2024-12-31) — Net PPE: 829191000.00
MRTN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -152089000.00
MRTN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 767922000.00
MRTN balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 107034000.00
MRTN balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 107034000.00
MRTN income_statement (annual, 2024-12-31) — Normalized EBITDA: 134931000.00
MRTN income_statement (annual, 2024-12-31) — Normalized Income: 23239909.48
MRTN cash_flow (annual, 2024-12-31) — Operating Cash Flow: 134814000.00
MRTN cash_flow (annual, 2024-12-31) — Operating Gains Losses: -4971000.00
MRTN income_statement (annual, 2024-12-31) — Operating Income: 28249000.00
MRTN income_statement (annual, 2024-12-31) — Operating Revenue: 963708000.00
MRTN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 81463938.00
MRTN balance_sheet (annual, 2024-12-31) — Other Current Assets: 2841000.00
MRTN income_statement (annual, 2024-12-31) — Other Gand A: 9029000.00
MRTN income_statement (annual, 2024-12-31) — Other Income Expense: 8097000.00
MRTN cash_flow (annual, 2024-12-31) — Other Non Cash Items: 6888000.00
MRTN balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1055000.00
MRTN income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 3126000.00
MRTN income_statement (annual, 2024-12-31) — Other Operating Expenses: 30012000.00
MRTN balance_sheet (annual, 2024-12-31) — Other Properties: 1029441000.00
MRTN balance_sheet (quarterly, 2024-12-31) — Other Properties: 1029441000.00
MRTN balance_sheet (annual, 2024-12-31) — Other Receivables: 6948000.00
MRTN income_statement (annual, 2024-12-31) — Other Taxes: 10302000.00
MRTN balance_sheet (annual, 2024-12-31) — Payables: 26846000.00
MRTN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 93519000.00
MRTN balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
MRTN balance_sheet (annual, 2024-12-31) — Prepaid Assets: 21463000.00
MRTN balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 21463000.00
MRTN income_statement (annual, 2024-12-31) — Pretax Income: 36346000.00
MRTN cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 1300000.00
MRTN balance_sheet (annual, 2024-12-31) — Properties: 108990000.00
MRTN balance_sheet (quarterly, 2024-12-31) — Properties: 108990000.00
MRTN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -233230000.00
MRTN balance_sheet (annual, 2024-12-31) — Receivables: 96940000.00
MRTN income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 833007000.00
MRTN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 111653000.00
MRTN cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
MRTN balance_sheet (annual, 2024-12-31) — Restricted Cash: 0.00
MRTN balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 0.00
MRTN balance_sheet (annual, 2024-12-31) — Retained Earnings: 714166000.00
MRTN cash_flow (annual, 2024-12-31) — Sale Of PPE: 81141000.00
MRTN income_statement (annual, 2024-12-31) — Selling General And Administration: 62138000.00
MRTN balance_sheet (annual, 2024-12-31) — Share Issued: 81463938.00
MRTN income_statement (annual, 2024-12-31) — Special Income Charges: 4971000.00
MRTN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 2236000.00
MRTN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 767922000.00
MRTN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 767922000.00
MRTN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 1288909.48
MRTN income_statement (annual, 2024-12-31) — Tax Provision: 9424000.00
MRTN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.26
MRTN balance_sheet (annual, 2024-12-31) — Total Assets: 968757000.00
MRTN balance_sheet (annual, 2024-12-31) — Total Capitalization: 767922000.00
MRTN balance_sheet (annual, 2024-12-31) — Total Debt: 282000.00
MRTN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 767922000.00
MRTN income_statement (annual, 2024-12-31) — Total Expenses: 935459000.00
MRTN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 200835000.00
MRTN balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 830246000.00
MRTN balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 107316000.00
MRTN income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 33220000.00
MRTN balance_sheet (annual, 2024-12-31) — Total Tax Payable: 1065000.00
MRTN balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 1065000.00
MRTN income_statement (annual, 2024-12-31) — Total Unusual Items: 4971000.00
MRTN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 4971000.00
MRTN balance_sheet (annual, 2024-12-31) — Working Capital: 44992000.00
MRTN income_statement (quarterly, 2025-03-31) — +Operating Expense: 26402000.00
MRTN income_statement (quarterly, 2025-03-31) — +Total Revenue: 223152000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 37783000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 95250000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -380321000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 53073000.00
MRTN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 81493000.00
MRTN income_statement (quarterly, 2025-03-31) — Basic EPS: 0.05
MRTN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 17267000.00
MRTN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -18842000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 385000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 815000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 39905000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 39905000.00
MRTN cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -4889000.00
MRTN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -5164000.00
MRTN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -8413000.00
MRTN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 36215000.00
MRTN cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 2282000.00
MRTN cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 4196000.00
MRTN cash_flow (quarterly, 2025-03-31) — Change In Payable: 2282000.00
MRTN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 6478000.00
MRTN cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 2387000.00
MRTN cash_flow (quarterly, 2025-03-31) — Change In Receivables: -3571000.00
MRTN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 5294000.00
MRTN cash_flow (quarterly, 2025-03-31) — Changes In Cash: 22638000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Common Stock: 815000.00
MRTN cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -4889000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 767500000.00
MRTN income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 192556000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 71840000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Current Assets: 162500000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 109623000.00
MRTN cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -1210000.00
MRTN cash_flow (quarterly, 2025-03-31) — Deferred Tax: -1210000.00
MRTN cash_flow (quarterly, 2025-03-31) — Depreciation: 27470000.00
MRTN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 27470000.00
MRTN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 27470000.00
MRTN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 81508000.00
MRTN income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.05
MRTN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 4335000.00
MRTN income_statement (quarterly, 2025-03-31) — EBIT: 4194000.00
MRTN income_statement (quarterly, 2025-03-31) — EBITDA: 31664000.00
MRTN cash_flow (quarterly, 2025-03-31) — End Cash Position: 39905000.00
MRTN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -5164000.00
MRTN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 17373000.00
MRTN cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -1665000.00
MRTN income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 1665000.00
MRTN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 15656000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1199378000.00
MRTN income_statement (quarterly, 2025-03-31) — Gross Profit: 30596000.00
MRTN income_statement (quarterly, 2025-03-31) — Insurance And Claims: 13377000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 767500000.00
MRTN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -8413000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 385000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 385000.00
MRTN income_statement (quarterly, 2025-03-31) — Net Income: 4335000.00
MRTN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 4335000.00
MRTN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 4335000.00
MRTN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 4335000.00
MRTN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 4335000.00
MRTN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 4335000.00
MRTN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 4335000.00
MRTN cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -284000.00
MRTN cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -52000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Net PPE: 819057000.00
MRTN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -8361000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 767500000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 105824000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 105824000.00
MRTN income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 29999000.00
MRTN income_statement (quarterly, 2025-03-31) — Normalized Income: 3172830.00
MRTN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 36215000.00
MRTN cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -1665000.00
MRTN income_statement (quarterly, 2025-03-31) — Operating Income: 4194000.00
MRTN income_statement (quarterly, 2025-03-31) — Operating Revenue: 223152000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 81493424.00
MRTN balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 22621000.00
MRTN income_statement (quarterly, 2025-03-31) — Other Gand A: 2279000.00
MRTN income_statement (quarterly, 2025-03-31) — Other Income Expense: 2014000.00
MRTN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1584000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1775000.00
MRTN income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 349000.00
MRTN income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 8329000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Other Receivables: 4724000.00
MRTN income_statement (quarterly, 2025-03-31) — Other Taxes: 2417000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Payables: 37783000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 109623000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
MRTN income_statement (quarterly, 2025-03-31) — Pretax Income: 6208000.00
MRTN cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 9000.00
MRTN cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -18842000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Receivables: 99974000.00
MRTN income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 192556000.00
MRTN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 27470000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 713612000.00
MRTN cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 10481000.00
MRTN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 15656000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Share Issued: 81493424.00
MRTN income_statement (quarterly, 2025-03-31) — Special Income Charges: 1665000.00
MRTN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 407000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 767500000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 767500000.00
MRTN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 502830.00
MRTN income_statement (quarterly, 2025-03-31) — Tax Provision: 1873000.00
MRTN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
MRTN balance_sheet (quarterly, 2025-03-31) — Total Assets: 983332000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 767500000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Total Debt: 385000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 767500000.00
MRTN income_statement (quarterly, 2025-03-31) — Total Expenses: 218958000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 215832000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 820832000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 106209000.00
MRTN income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 5859000.00
MRTN income_statement (quarterly, 2025-03-31) — Total Unusual Items: 1665000.00
MRTN income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 1665000.00
MRTN balance_sheet (quarterly, 2025-03-31) — Working Capital: 52877000.00
MRTN income_statement (quarterly, 2025-06-30) — +Operating Expense: 28173000.00
MRTN income_statement (quarterly, 2025-06-30) — +Total Revenue: 229922000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 44894000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 91432000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -373131000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 53994000.00
MRTN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 81510000.00
MRTN income_statement (quarterly, 2025-06-30) — Basic EPS: 0.09
MRTN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 39905000.00
MRTN cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -56971000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 317000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 815000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 35052000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 35052000.00
MRTN cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -4891000.00
MRTN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -4891000.00
MRTN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -33115000.00
MRTN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 33153000.00
MRTN cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 47000.00
MRTN cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 79000.00
MRTN cash_flow (quarterly, 2025-06-30) — Change In Payable: 47000.00
MRTN cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 126000.00
MRTN cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -271000.00
MRTN cash_flow (quarterly, 2025-06-30) — Change In Receivables: 3158000.00
MRTN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 3013000.00
MRTN cash_flow (quarterly, 2025-06-30) — Changes In Cash: -4853000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Common Stock: 815000.00
MRTN cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -4891000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 770716000.00
MRTN income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 197197000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 71791000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Current Assets: 155813000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 116685000.00
MRTN cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -1726000.00
MRTN cash_flow (quarterly, 2025-06-30) — Deferred Tax: -1726000.00
MRTN cash_flow (quarterly, 2025-06-30) — Depreciation: 27307000.00
MRTN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 27307000.00
MRTN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 27307000.00
MRTN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 81517000.00
MRTN income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.09
MRTN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 7186000.00
MRTN income_statement (quarterly, 2025-06-30) — EBIT: 4552000.00
MRTN income_statement (quarterly, 2025-06-30) — EBITDA: 31859000.00
MRTN cash_flow (quarterly, 2025-06-30) — End Cash Position: 35052000.00
MRTN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -4891000.00
MRTN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -23818000.00
MRTN cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -5182000.00
MRTN income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 5182000.00
MRTN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 18016000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1207399000.00
MRTN income_statement (quarterly, 2025-06-30) — Gross Profit: 32725000.00
MRTN income_statement (quarterly, 2025-06-30) — Insurance And Claims: 15852000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 770716000.00
MRTN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -33115000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 317000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 317000.00
MRTN income_statement (quarterly, 2025-06-30) — Net Income: 7186000.00
MRTN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 7186000.00
MRTN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 7186000.00
MRTN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 7186000.00
MRTN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 7186000.00
MRTN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 7186000.00
MRTN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 7186000.00
MRTN cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 0.00
MRTN cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 0.00
MRTN balance_sheet (quarterly, 2025-06-30) — Net PPE: 834268000.00
MRTN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -33115000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 770716000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 104098000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 104098000.00
MRTN income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 26677000.00
MRTN income_statement (quarterly, 2025-06-30) — Normalized Income: 3522326.00
MRTN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 33153000.00
MRTN cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -5182000.00
MRTN income_statement (quarterly, 2025-06-30) — Operating Income: 4552000.00
MRTN income_statement (quarterly, 2025-06-30) — Operating Revenue: 229922000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 81520424.00
MRTN balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 21942000.00
MRTN income_statement (quarterly, 2025-06-30) — Other Gand A: 2164000.00
MRTN income_statement (quarterly, 2025-06-30) — Other Income Expense: 5618000.00
MRTN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 1634000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1735000.00
MRTN income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 436000.00
MRTN income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 7706000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Other Receivables: 7387000.00
MRTN income_statement (quarterly, 2025-06-30) — Other Taxes: 2451000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Payables: 44894000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 116685000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
MRTN income_statement (quarterly, 2025-06-30) — Pretax Income: 10170000.00
MRTN cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
MRTN cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -56971000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Receivables: 98819000.00
MRTN income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 197197000.00
MRTN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 27307000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 715907000.00
MRTN cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 23856000.00
MRTN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 18016000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Share Issued: 81520424.00
MRTN income_statement (quarterly, 2025-06-30) — Special Income Charges: 5182000.00
MRTN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 921000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 770716000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 770716000.00
MRTN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 1518326.00
MRTN income_statement (quarterly, 2025-06-30) — Tax Provision: 2984000.00
MRTN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.29
MRTN balance_sheet (quarterly, 2025-06-30) — Total Assets: 991816000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 770716000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Total Debt: 317000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 770716000.00
MRTN income_statement (quarterly, 2025-06-30) — Total Expenses: 225370000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 221100000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 836003000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 104415000.00
MRTN income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 9734000.00
MRTN income_statement (quarterly, 2025-06-30) — Total Unusual Items: 5182000.00
MRTN income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 5182000.00
MRTN balance_sheet (quarterly, 2025-06-30) — Working Capital: 39128000.00
MRTN income_statement (quarterly, 2025-09-30) — +Operating Expense: 23821000.00
MRTN income_statement (quarterly, 2025-09-30) — +Total Revenue: 220470000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 39744000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 92011000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -355266000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 54143000.00
MRTN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 81520000.00
MRTN income_statement (quarterly, 2025-09-30) — Basic EPS: 0.03
MRTN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 35052000.00
MRTN cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -49249000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 250000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 815000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 49485000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 49485000.00
MRTN cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -4891000.00
MRTN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -4891000.00
MRTN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 5786000.00
MRTN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 18538000.00
MRTN cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 6191000.00
MRTN cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 4142000.00
MRTN cash_flow (quarterly, 2025-09-30) — Change In Payable: 6191000.00
MRTN cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 10333000.00
MRTN cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -4203000.00
MRTN cash_flow (quarterly, 2025-09-30) — Change In Receivables: -2617000.00
MRTN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 3513000.00
MRTN cash_flow (quarterly, 2025-09-30) — Changes In Cash: 19433000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Common Stock: 815000.00
MRTN cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -4891000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 768200000.00
MRTN income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 195814000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 75840000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Current Assets: 175993000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 115584000.00
MRTN cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -12481000.00
MRTN cash_flow (quarterly, 2025-09-30) — Deferred Tax: -12481000.00
MRTN cash_flow (quarterly, 2025-09-30) — Depreciation: 25447000.00
MRTN cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 25447000.00
MRTN cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 25447000.00
MRTN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 81527000.00
MRTN income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.03
MRTN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 2226000.00
MRTN income_statement (quarterly, 2025-09-30) — EBIT: 835000.00
MRTN income_statement (quarterly, 2025-09-30) — EBITDA: 26282000.00
MRTN cash_flow (quarterly, 2025-09-30) — End Cash Position: 54485000.00
MRTN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -4891000.00
MRTN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -30711000.00
MRTN cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: -1903000.00
MRTN income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 1903000.00
MRTN income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 13475000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1148269000.00
MRTN income_statement (quarterly, 2025-09-30) — Gross Profit: 24656000.00
MRTN cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 7112000.00
MRTN income_statement (quarterly, 2025-09-30) — Insurance And Claims: 11382000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 768200000.00
MRTN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 5786000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 250000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 250000.00
MRTN income_statement (quarterly, 2025-09-30) — Net Income: 2226000.00
MRTN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 2226000.00
MRTN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 2226000.00
MRTN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2226000.00
MRTN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2226000.00
MRTN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 2226000.00
MRTN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 2226000.00
MRTN cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
MRTN cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 0.00
MRTN balance_sheet (quarterly, 2025-09-30) — Net PPE: 793003000.00
MRTN cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 5786000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 768200000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 91617000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 91617000.00
MRTN income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 24379000.00
MRTN income_statement (quarterly, 2025-09-30) — Normalized Income: 791138.00
MRTN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 18538000.00
MRTN cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -1903000.00
MRTN income_statement (quarterly, 2025-09-30) — Operating Income: 835000.00
MRTN income_statement (quarterly, 2025-09-30) — Operating Revenue: 220470000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 81520424.00
MRTN balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 25296000.00
MRTN income_statement (quarterly, 2025-09-30) — Other Gand A: 2093000.00
MRTN income_statement (quarterly, 2025-09-30) — Other Income Expense: 2116000.00
MRTN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1587000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 6655000.00
MRTN income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 213000.00
MRTN income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 7923000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Other Receivables: 9201000.00
MRTN income_statement (quarterly, 2025-09-30) — Other Taxes: 2423000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Payables: 39744000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 115584000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
MRTN income_statement (quarterly, 2025-09-30) — Pretax Income: 2951000.00
MRTN cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
MRTN cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -49249000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Receivables: 101212000.00
MRTN income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 195814000.00
MRTN income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 25447000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 713242000.00
MRTN cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 55035000.00
MRTN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 13475000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Share Issued: 81520424.00
MRTN income_statement (quarterly, 2025-09-30) — Special Income Charges: 1903000.00
MRTN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 149000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 768200000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 768200000.00
MRTN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 468138.00
MRTN income_statement (quarterly, 2025-09-30) — Tax Provision: 725000.00
MRTN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
MRTN balance_sheet (quarterly, 2025-09-30) — Total Assets: 975651000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 768200000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Total Debt: 250000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 768200000.00
MRTN income_statement (quarterly, 2025-09-30) — Total Expenses: 219635000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 207451000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 799658000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 91867000.00
MRTN income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 2738000.00
MRTN income_statement (quarterly, 2025-09-30) — Total Unusual Items: 1903000.00
MRTN income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 1903000.00
MRTN balance_sheet (quarterly, 2025-09-30) — Working Capital: 60409000.00
MRTN income_statement (annual, 2025-12-31) — +Operating Expense: 105024000.00
MRTN income_statement (quarterly, 2025-12-31) — +Operating Expense: 26628000.00
MRTN income_statement (annual, 2025-12-31) — +Total Revenue: 883652000.00
MRTN income_statement (quarterly, 2025-12-31) — +Total Revenue: 210108000.00
MRTN balance_sheet (annual, 2025-12-31) — Accounts Payable: 28769000.00
MRTN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 28769000.00
MRTN balance_sheet (annual, 2025-12-31) — Accounts Receivable: 85807000.00
MRTN balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 85807000.00
MRTN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -352426000.00
MRTN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -352426000.00
MRTN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 54762000.00
MRTN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 54762000.00
MRTN balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -400000.00
MRTN balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -400000.00
MRTN income_statement (annual, 2025-12-31) — Basic Average Shares: 81512000.00
MRTN income_statement (quarterly, 2025-12-31) — Basic Average Shares: 81524000.00
MRTN income_statement (annual, 2025-12-31) — Basic EPS: 0.21
MRTN income_statement (quarterly, 2025-12-31) — Basic EPS: 0.05
MRTN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 17267000.00
MRTN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 54485000.00
MRTN cash_flow (annual, 2025-12-31) — Capital Expenditure: -144553000.00
MRTN cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -19491000.00
MRTN balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 194000.00
MRTN balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 194000.00
MRTN balance_sheet (annual, 2025-12-31) — Capital Stock: 815000.00
MRTN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 815000.00
MRTN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 43278000.00
MRTN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 43278000.00
MRTN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 43278000.00
MRTN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 43278000.00
MRTN cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -19562000.00
MRTN cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -4891000.00
MRTN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -19600000.00
MRTN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4654000.00
MRTN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -42877000.00
MRTN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -7135000.00
MRTN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 93488000.00
MRTN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 5582000.00
MRTN cash_flow (annual, 2025-12-31) — Change In Account Payable: -1499000.00
MRTN cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -10019000.00
MRTN cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -3942000.00
MRTN cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -12359000.00
MRTN cash_flow (annual, 2025-12-31) — Change In Payable: -1499000.00
MRTN cash_flow (quarterly, 2025-12-31) — Change In Payable: -10019000.00
MRTN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -5441000.00
MRTN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -22378000.00
MRTN cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -2121000.00
MRTN cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -34000.00
MRTN cash_flow (annual, 2025-12-31) — Change In Receivables: -661000.00
MRTN cash_flow (quarterly, 2025-12-31) — Change In Receivables: 2369000.00
MRTN cash_flow (annual, 2025-12-31) — Change In Working Capital: -8223000.00
MRTN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -20043000.00
MRTN cash_flow (annual, 2025-12-31) — Changes In Cash: 31011000.00
MRTN cash_flow (quarterly, 2025-12-31) — Changes In Cash: -6207000.00
MRTN balance_sheet (annual, 2025-12-31) — Common Stock: 815000.00
MRTN balance_sheet (quarterly, 2025-12-31) — Common Stock: 815000.00
MRTN cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -19562000.00
MRTN cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -4891000.00
MRTN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 767625000.00
MRTN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 767625000.00
MRTN income_statement (annual, 2025-12-31) — Cost Of Revenue: 767782000.00
MRTN income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 182215000.00
MRTN balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 63463000.00
MRTN balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 63463000.00
MRTN balance_sheet (annual, 2025-12-31) — Current Assets: 171701000.00
MRTN balance_sheet (quarterly, 2025-12-31) — Current Assets: 171701000.00
MRTN balance_sheet (annual, 2025-12-31) — Current Liabilities: 92232000.00
MRTN balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 92232000.00
MRTN cash_flow (annual, 2025-12-31) — Deferred Income Tax: -17318000.00
MRTN cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -1901000.00
MRTN cash_flow (annual, 2025-12-31) — Deferred Tax: -17318000.00
MRTN cash_flow (quarterly, 2025-12-31) — Deferred Tax: -1901000.00
MRTN cash_flow (annual, 2025-12-31) — Depreciation: 105392000.00
MRTN cash_flow (quarterly, 2025-12-31) — Depreciation: 25168000.00
MRTN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 105392000.00
MRTN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 25168000.00
MRTN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 105392000.00
MRTN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 25168000.00
MRTN income_statement (annual, 2025-12-31) — Diluted Average Shares: 81519000.00
MRTN income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 81530000.00
MRTN income_statement (annual, 2025-12-31) — Diluted EPS: 0.21
MRTN income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.05
MRTN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 17444000.00
MRTN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 3697000.00
MRTN income_statement (annual, 2025-12-31) — EBIT: 10846000.00
MRTN income_statement (quarterly, 2025-12-31) — EBIT: 1265000.00
MRTN income_statement (annual, 2025-12-31) — EBITDA: 116238000.00
MRTN income_statement (quarterly, 2025-12-31) — EBITDA: 26433000.00
MRTN cash_flow (annual, 2025-12-31) — End Cash Position: 48278000.00
MRTN cash_flow (quarterly, 2025-12-31) — End Cash Position: 48278000.00
MRTN cash_flow (annual, 2025-12-31) — Financing Cash Flow: -19600000.00